Revision of the EU general pharmaceutical legislation - addressing challenges, seizing opportunities

13 March 2023 | 18:00-19:30 | Permanent Representation of Austria to the European Union, Brussels

In March 2023, the European Commission is due to publish its proposal for the upcoming revision of the EU pharmaceutical legislation, to ensure a future-proof and crisis-resistant regulatory system.  In this event key, experts will consider the opportunities and lessons learned from the pandemic and discuss how to ensure the security of access to and supply of medicines for all even in times of crisis, while fostering innovation and investment in research and striving for a new dialogue between public and private sector.

This event was organised in close cooperation with the Federal Ministry of Social Affairs, Health, Care and Consumer Protection, Austria and the Permanent Representation of Austria to the European Union.

Read the op-ed by EHFG President, Dr Clemens Martin Auer, on the subject here

Watch the recording


Speakers and moderator

Johannes Rauch

Federal Minister of Social Affairs, Health, Care and Consumer Protection, Austria

Christopher Fearne

Deputy Prime Minister and Minister for Health, Malta

Stella Kyriakides

European Commissioner for Health and Food Safety

Emer Cooke

Executive Director, European Medicines Agency

Sylvia Maurer

Director, The European Consumer Organisation

Adrian van den Hoven

Director General, Medicines for Europe

Karla van Rooijen

Director of Pharmaceuticals and Medical Technology Department, Ministry of Health, Welfare and Sport, The Netherlands

Petra Wilson

Co-founder and managing director, Health Connect Partners

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office

VAT No. ATU44155007 Bank Data:
IBAN AT 152040400200222240 
Bank Salzburger Sparkasse
Kurgartenstraße, 5630 Bad Hofgastein, Austria